✦ LIBER ✦

Enhancing the Efficacy of Hepatocellular Carcinoma Chemotherapeutics with Natural Anticancer Agents

✍ Scribed by A. Alisi; C. Balsano

Book ID: 109381266
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 52 KB
Volume: 65
Category: Article
ISSN: 0029-6643
DOI: 10.1111/j.1753-4887.2007.tb00280.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sorafenib enhances the chemotherapeutic

Sorafenib enhances the chemotherapeutic efficacy of S-1 against hepatocellular carcinoma through downregulation of transcription factor E2F-1

✍ Zhai, Jing-Ming; Yin, Xiao-Yu; Lai, Ying-Rong; Hou, Xun; Cai, Jian-Peng; Hao, Xi 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 628 KB

Antiangiogenic therapy enhances the effi

Antiangiogenic therapy enhances the efficacy of transcatheter arterial embolization for hepatocellular carcinomas

✍ Hongchi Jiang; Qinghui Meng; Hongtao Tan; Shangha Pan; Bei Sun; Ruian Xu; Xueyin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 660 KB

## Abstract Transcatheter arterial embolization (TAE) is a well‐established technique for unresectable hepatic malignancies. However, TAE can temporally halt the growth of hepatic tumors by blocking their arterial supply, but often tumors rapidly develop collateral blood vessels __via__ angiogenesi

Usefulness of miriplatin as an anticance

Usefulness of miriplatin as an anticancer agent for transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma

✍ Yukinori Imai; Taku Chikayama; Manabu Nakazawa; Kazuhiro Watanabe; Satsuki Ando; 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 183 KB

Risk factors for the leakage of chemothe

Risk factors for the leakage of chemotherapeutic agents into systemic circulation after transcatheter arterial chemoembolization of hepatocellular carcinoma

✍ Ming-Yen Hsieh; Zu-Yau Lin; Su-Hwei Chen; Wan-Long Chuang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 230 KB

The efficacy of stereotactic body radiot

The efficacy of stereotactic body radiotherapy for patients with hepatocellular carcinoma

✍ Hongzhen Zhang; Yazhen Wang; Ning Xu; Xinbo Duan; Chaoying Ren 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 190 KB

Mo2075 Triptolide Demonstrates Novel Che

Mo2075 Triptolide Demonstrates Novel Chemotherapeutic Potential as Single-Agent or Combination Therapy With Sorafenib for Treatment of Hepatocellular Carcinoma

✍ Krosch, Tara C.; Sangwan, Veena; Banerjee, Sulagna; Saluja, Ashok; Jensen, Eric 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 257 KB